Login / Signup

Title Personalized cancer nanomedicine: Overcoming biological barriers for intracellular delivery of biopharmaceuticals.

Ana María López-EstévezPhilipp LapuhsLaura Pineiro-AlonsoMaría José Alonso
Published in: Advanced materials (Deerfield Beach, Fla.) (2023)
The success of personalized medicine in oncology relies on using highly effective and precise therapeutic modalities such as small interfering RNA (siRNA) and monoclonal antibodies (mAbs). Unfortunately, the clinical exploitation of these biological drugs has encountered obstacles in overcoming intricate biological barriers. Drug delivery technologies represent a plausible strategy to overcome such barriers, ultimately facilitating the access to intracellular domains. Here, an overview of the current landscape on how nanotechnology has dealt with protein corona phenomena as a first and determinant biological barrier is presented. This continues with the analysis of strategies facilitating access to the tumor, along with conceivable methods for enhanced tumor penetration. As a final step, the cellular barriers that nanocarriers must confront in order for their biological cargo to reach their target are deeply analyzed. The review concludes with a critical analysis and future perspectives of the translational advances in personalized oncological nanomedicine. This article is protected by copyright. All rights reserved.
Keyphrases
  • drug delivery
  • cancer therapy
  • prostate cancer
  • palliative care
  • papillary thyroid
  • rectal cancer
  • small molecule
  • radical prostatectomy
  • young adults